AstraZeneca PLC - Enterprise Value To Ebitda Ratio

AstraZeneca PLC's Fiscal Year is From January To December.

The item "Enterprise-Value-To-Ebitda-Ratio" stands at 17.56 as of 09/30/2025.

As of the end of AstraZeneca PLC's third quarter, the item "Enterprise Value To Ebitda Ratio" stands at 17.56. This represents a decrease of -0.97 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 3.34 percent compared to the value the year prior.
The 1 year change in percent is 3.34.
The 3 year change in percent is -21.23.

The Serie's long term average value is 19.90. It's latest available value, on 09/30/2025, is 11.78 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2024, to it's latest available value, on 09/30/2025, is +35.27%.
The Serie's change in percent from it's maximum value, on 06/30/2022, to it's latest available value, on 09/30/2025, is -43.91%.